CONSTELLATION PHARMACEUTICALS INC — Form D

CONSTELLATION PHARMACEUTICALS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-06-02. The offering totals $22.3M, of which $22.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Robert K TepperDirectorCambridge, MA
Edward E Harlow, Jr.Executive OfficerCambridge, MA
Kerry K ReinertsenExecutive OfficerCambridge, MA
Peter SvennilsonDirectorSouth San Francisco, CA
Jigar RaythathaDirectorBoston, MA
Jigar RaythathaExecutive OfficerBoston, MA
David GoeddelDirectorAgoura Hills, CA
Elizabeth G TrehuDirectorCambridge, MA
Mark A GoldsmithDirectorRedwood City, CA
Mark A GoldsmithExecutive OfficerRedwood City, CA
Anthony EvninDirectorCambridge, MA
Robert A TepperDirectorCambridge, MA
James E AudiaDirectorCambridge, MA
James E AudiaExecutive OfficerCambridge, MA
Patrick G TrojerExecutive OfficerCambridge, MA
Steven G HoerterDirectorCambridge, MA
Scott G BraunsteinDirectorCambridge, MA
Adrian G SenderowiczExecutive OfficerCambridge, MA
Karen G ValentineExecutive OfficerCambridge, MA
Emma E ReeveExecutive OfficerCambridge, MA
Keith DionneDirectorBelmont, MA
Keith DionneExecutive OfficerBelmont, MA
Anthony A EvninDirectorCambridge, MA
Michael R CooperExecutive OfficerCambridge, MA
Matthias E JaffeExecutive OfficerCambridge, MA

Other filings by this issuer (6)

FiledFormOfferingSold
2019-10-08D$65.0M$65.0M
2018-04-06D$100.0M$99.0M
2016-09-27D$24.3M$24.3M
2015-12-15D$55.8M$55.8M
2014-08-05D$5.0M$5.0M
2011-06-06D$15.0M$15.0M

More